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We previously found that human amniotic mesenchymal stem cells (hAMSCs) in coculture with CF immortalised airway epithelial
cells (CFBE41o- line, CFBE) on Transwell® ﬁlters acquired an epithelial phenotype and led to the expression of a mature and
functional CFTR protein. In order to explore the role of gap junction- (GJ-) mediated intercellular communication (GJIC) in
this rescue, cocultures (hAMSC : CFBE, 1 : 5 ratio) were studied for the formation of GJIC, before and after silencing connexin
43 (Cx43), a major component of GJs. Functional GJs in cocultures were inhibited when the expression of the Cx43 protein was
downregulated. Transfection of cocultures with siRNA against Cx43 resulted in the absence of speciﬁc CFTR signal on the
apical membrane and reduction in the mature form of CFTR (band C), and in parallel, the CFTR-dependent chloride channel
activity was signiﬁcantly decreased. Cx43 downregulation determined also a decrease in transepithelial resistance and an
increase in paracellular permeability as compared with control cocultures, implying that GJIC may regulate CFTR expression
and function that in turn modulate airway epithelium tightness. These results indicate that GJIC is involved in the correction of
CFTR chloride channel activity upon the acquisition of an epithelial phenotype by hAMSCs in coculture with CF cells.
1. Introduction
Respiratory disease is the major cause of morbidity and
mortality for cystic ﬁbrosis (CF) patients, who on average sur-
vive up to 40 years of age. CF is an autosomal recessive dis-
ease, caused by genetic defects in the CF transmembrane
conductance regulator (CFTR) gene on the long arm of chro-
mosome 7. More than 2000 mutations in this gene have been
described to date (http://www.genet.sickkids.on.ca/app, last
access June 20, 2017), although the deletion of phenylalanine
at position 508 (F508del) represents the most frequent muta-
tion, being present in 70% of CF chromosomes worldwide
[1]. The F508del CFTR protein is defective in its processing
at the level of the endoplasmic reticulum and is directed to
the degradation in the proteasome resulting in very low levels
of the protein at the apical plasma membrane of airway
epithelial cells. The lack of CFTR at the membrane region
impairs not only chloride eﬄux in the airway lumen but also
the absorption of sodium ions by epithelial cells, since wild-
type CFTR exerts a negative tonic eﬀect on the epithelial
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sodium (ENaC) channel [2]. Therefore, lack/dysfunction of
CFTR eventually leads to dehydration of airway secretions,
ablation of the mucociliary clearance, and airway colonisa-
tion and infection by opportunistic bacterial pathogens,
including the gram-negative Pseudomonas aeruginosa [3].
Although this pathophysiologic process is the most accepted
model, with a notable exception in the CF pigs (where the
basic defect involves the regulation of bicarbonate secretion
and the pH of airway secretions) [4], nevertheless, other
defects in airway epithelial cells have been described,
involving the actin cytoskeleton and the tightness of the
epithelium. NHERF1, ezrin, and protein kinase A form a
multiprotein complex which tethers CFTR on the apical
plasma membrane of airway epithelial cells and guarantees
its correct functioning as a chloride channel [5]. In CF cells,
homozygous for F508del CFTR, this complex is disrupted
and CFTR delocalisation and degradation are associated
with disorganization of actin cytoskeleton and tight junction
leakiness [6–8].
CF, particularly its lung manifestations, at the moment
has no cure. The increase in the median age of survival for
CF patients observed in recent years is due to the improve-
ments in chest physiotherapy and antibiotic regimens [9].
New perspectives are oﬀered by the introduction of drugs
which can correct the F508del processing defect and potenti-
ate its channel activity [10]. The corrector lumacaftor, the
ﬁrst introduced in the clinics, exerts a limited eﬃcacy on
F508del homozygous patients at the lung function level [11].
Stem cell-based therapies could have the advantage of
replenishing the niche of the damaged airway epithelium
and allow a long-term correction of the underlying basic
defects, irrespective of the mutation. Among the possible
sources of stem cells for the treatment of lung diseases,
embryonic stem cells (ESCs) and induced-pluripotent stem
cells (iPSCs) hold interesting properties for their capacity to
give rise to a completely diﬀerentiated airway epithelium
and therefore are useful for airway mucosal repair [12];
however, their employment is limited by concerns regard-
ing tumor formation (both ESCs and iPSCs) and immune
response (ESCs). Mesenchymal stem cells (MSCs) are derived
from adult tissue and have been evaluated as a potential
cell-based therapy for lung diseases [13], including CF
[14]. MSCs derived from the amniotic membrane (AMSCs)
are considered as a novel cell source for cell transplantation
and regenerative medicine [15]. Human AMSCs (hAMSCs)
have gained particular attention in this context also because
they are obtained from a discarded material after delivery
(i.e., the placenta) and have been used as an amniotic mem-
brane in the clinical setting for more than 100 years [16].
hAMSCs have been shown to have beneﬁcial eﬀects when
administered in animal models for a large number of dis-
eases, including lung injury [17] and pulmonary ﬁbrosis
[18, 19]. We have previously shown that hAMSCs display
the ability to diﬀerentiate into airway epithelial cells and
determine an increase in CFTR maturation and CFTR-
dependent chloride eﬄux in cocultures with immortalised
CF bronchial epithelial cells (CFBE41o- line) [20]. Since the
correction was not achieved when hAMSCs were cultured
separately from CFBE41o- (CFBE) cells, we hypothesised
that gap junction (GJ) intercellular communication (GJIC)
is likely to have a role in the rescue of basic defects in the
CF airway epithelium.
GJs are important for cell-to-cell communication in
diﬀerent processes such as cell morphogenesis, proliferation,
and diﬀerentiation. They allow the exchange between cells of
low molecular weight metabolites, like amino acids, glucose,
nucleotides, and second messengers, such as calcium ions,
cAMP, ATP, IP3, and small RNAs [21]. GJs are made by
docking of two hexameric hemichannels (connexons) of
two apposed cells, thus composed of 12 proteins called
connexins. More than 20 members have been identiﬁed with
a wide variability in their tissue distribution [22]. Connexin
43 (Cx43) is ubiquitously expressed in normal tissue of the
airways [23, 24] and has been one of the most studied
connexins in the functional and immunological evaluation
of airway epithelial cells [25–28]. As concerning CF, it has
been previously shown that Cx43-mediated GJ intercellular
communication (GJIC) coordinates a signaling network to
activate CFTR and modulate airway surface liquid volume
in Calu-3 cells [27]. Moreover, Cx43 expression is induced
by the PAO1 strain of P. aeruginosa leading to a regulated
increase in GJIC [26], likely being part of the innate immune
response orchestrated by airway epithelial cells.
In this study, we have investigated the role of Cx43
and GJIC in the rescue of CFTR-dependent chloride eﬄux
in coculture of CFBE cells with hAMSCs. Downregulation
of Cx43 by siRNA transfection inhibited the formation of
GJs and ablated the recovery of chloride eﬄux as well as
the increment in transepithelial resistance. Overall, the
data strongly indicate that the resumption of CFTR func-
tional expression in CFBE : hAMSCs cocultures is mediated
by GJIC.
2. Materials and Methods
2.1. Cell Cultures. hAMSCs were isolated from term placenta
and grown in advanced DMEM supplemented with 10% FBS
(heat-inactivated foetal bovine serum), 55μM β-mercap-
toethanol, 1% L-glutamine, 1% penicillin/streptomycin (all
purchased from Thermo Fisher Scientiﬁc, Milan, Italy), and
10ng/ml epidermal growth factor (EGF) (Sigma-Aldrich,
Milan, Italy) [20]. Overall, in this study, we used six
hAMSC isolates: three for analysis of Cx43 mRNA/protein
expression and GJIC and another three for analysis of
CFTR protein expression/function and paracellular perme-
ability. Human immortalised bronchial epithelial cell lines
were 16HBE14o- (16HBE), expressing wild-type CFTR, and
CFBE41o- (CFBE), homozygous for the F508del allele [29].
Cells were grown at 37°C under 5% CO2 on ﬂasks in
MEM medium containing 10% FBS, 1% L-glutamine, and
1% penicillin/streptomycin.
Polarised cocultures were obtained by mixing hAMSCs
at passage two with CFBE cells at ratio 1 : 5 (2× 104
hAMSCs mixed with 8× 104 CFBE cells). Mixed cells were
seeded on 6.5mm diameter Transwell, 0.4μm pore size
(Corning, Acton, MA, USA) at 1× 105 per ﬁlter coated with
a solution of 10μg/ml ﬁbronectin (BD Biosciences, San Jose,
CA, USA), 100μg/ml albumin from bovine serum (Sigma-
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Aldrich), and 30μg/ml bovine collagen type I (BD Biosci-
ences) dissolved in MEM. As controls, hAMSCs and epithe-
lial cells were seeded at 2.5× 104 and 1× 105, respectively,
per ﬁlter. Either single cultures or cocultures were analysed
when conﬂuent monolayers were obtained, for example, at
6 days. In some experiments, 1× 105 mixed cells were seeded
onto either 24-well plates or glass slides positioned into
10 cm Petri dishes; conﬂuency was obtained also under these
experimental conditions.
2.2. Evaluation of Transfection Eﬃciency of Small Interfering
RNA. Cocultures were investigated for their capability to
uptake small interfering RNA (siRNA) by transfecting
them with Quasar 570-conjugated hGAPDH siRNA (Riboxx
GmbH, Radebeul, Germany) complexed with polyethyleni-
mine (PEI 25 kDa; Sigma-Aldrich), to enhance the siRNA
delivery. Complexes were prepared by mixing 10 nM PEI to
30 nM hGAPDH siRNA (N/P=7) and then incubated for
30min at room temperature. The complexes were added with
200μl of Opti-MEM (Thermo Fisher Scientiﬁc) and were
distributed to each coculture mixing before seeding 1× 105
mixed cells onto 24-well plates.
At 24 h posttransfection, cells in cocultures, treated or
not treated with trypan blue 0.04% in PBS in order to
quench extracellular ﬂuorescence, were detached with
trypsin/ethylenediaminetetraacetic acid (EDTA) and ﬁnally
resuspended in 50μl PBS. Cells were analysed by ﬂow cytom-
etry with the FlowSight® IS100 Flow Cytometer (Amnis;
Merck Millipore). Brightﬁeld aspect ratio versus brightﬁeld
area plots were generated to identify single cell events. The
percentage of positive cells was determined after setting the
gating on 99% of an untransfected control population of
cells and by subtracting the ﬂuorescence of these cells. Ten
thousand cells were examined for each sample by using
Amnis IDEAS software. Cells were excited with a 488 nm
laser light and the percentage of positive cells (emission at
575nm) was detected.
2.3. Downregulation of Cx43 mRNA and Protein. To obtain
the downregulation of Cx43 mRNA and protein, polarised
cocultures were treated by transfecting active siRNA pool
directed against Cx43 (Riboxx) complexed with 10 nM
PEI 25 KDa at N/P=7, as described above. In the same
experiments, untransfected and cocultures transfected with
scrambled negative control siRNA (Riboxx) were included.
Finally, the complexes were distributed to each coculture,
before seeding 1× 105 mixed cells onto Transwell ﬁlters.
2.4. Real-Time Quantitative PCR. Cx43 mRNA expression
was investigated by real-time PCR analysis. Total RNA
was isolated from cells grown under diﬀerent conditions
by using TRIzol™ Reagent (Thermo Fisher Scientiﬁc),
according to the manufacturer’s protocol. One microgram
of RNA was reverse transcribed into ﬁrst strand cDNA
with the High-Capacity cDNA Reverse Transcription kit
(Thermo Fisher Scientiﬁc) by using random primers fol-
lowing manufacturer’s instructions.
To evaluate the Cx43 expression, a SYBR® Green-based
real-time PCR assay using the comparative method (on the
Mx3005P Stratagene instrument, La Jolla, CA, USA) was
carried out. PCRs were set up in triplicate in a total volume
of 25μl per capillary. One reaction mixture contained
12.5μl of Brilliant SYBR Green QPCR Master Mix from
Stratagene, including a SureStart Taq DNA polymerase, a
dNTP mixture and SYBR Green, MgCl2 (2.5mM), 0.1μl of
forward and reverse primers each (ﬁnal concentration:
200 nM), 0.375μl of diluted reference dye (ﬁnal concentra-
tion: 30 nM), 1μl cDNA, and 10.925μl H2O. β-Actin was
used as endogenous control (normalizer). The cycling con-
ditions were as follows: an initial activation step of 95°C
for 10min followed by 40 cycles of denaturation of 95°C
for 30 sec, annealing at 57°C for 1min and extension at
72°C for 30 sec. Primer sequences for ampliﬁcation were
Cx43 forward TCGGGTTAAGGGAAAGAG and Cx43
reverse GCTCACTTGCTTGCTTGT.
2.5. Evaluation of Gap Junctional Intercellular Communication
(GJIC). Levels of GJIC in cocultures, untransfected and
transfected with active or scrambled negative control
siRNA, were determined by microinjection of ﬂuorescent
Lucifer Yellow (LY) dye into cells and by evaluation of
dye spread to adjacent cells [30]. Mixed hAMSC :CFBE
cells were treated with either Cx43 siRNA or scrambled
siRNA and then seeded onto glass slides. As a control,
mercury (II) chloride (Honeywell Fluka™, Thermo Fisher
Scientiﬁc) was added to 5-day cocultures at the ﬁnal
concentration of 10 nM. After 6 days, ﬁve cells per cocul-
ture were microinjected with a solution of 5mg/ml of the
membrane-permeant dye LY (Molecular Probes, Eugene,
OR, USA) together with 0.5μg/ml TRITC-dextran 10 kDa
(Molecular Probes) by the micromanipulator 5171 and
the transinjector 5246 (Eppendorf, Germany). Ten minutes
after injection, cells were washed with PBS and ﬁxed with
4% paraformaldehyde (PFA). The glass slide was mounted
onto a coverslip in the presence of a drop of VECTA-
SHIELD Antifade Mounting Medium with DAPI (Vector
Laboratories, Burlingame, CA, USA). In other experiments,
mixed cells were transfected or left untreated and seeded on
Transwell for 6 days and then evaluated for LY diﬀusion.
The ﬂuorescence was imaged by a Nikon IntensilightC-
HGFI (Nikon, Florence, Italy) through a 60x oil immersion
objective. The microscope was equipped with a DAPI ﬁlter
(358 nm excitation; 461 nm emission), FITC ﬁlter (490 nm
excitation; 525 nm emission), and a TRITC ﬁlter (532 nm
excitation; 570 nm emission). Digital images were processed
using the NISE elements program (Nikon).
2.6. Immunoﬂuorescence and Confocal Analysis. Polarised
cells or cocultures were washed three times with PBS and
incubated in 2% BSA/PBS for 30min on ice. Cells were incu-
bated with an anti-CFTR (CF3) mouse monoclonal antibody
(dilution 1 : 500; Abcam) followed by a goat anti-mouse IgG
conjugated to Alexa Fluor 488 (dilution 1 : 1000; Invitrogen)
used as secondary antibody or with an anti-Cx43 (CX-1B1)
mouse monoclonal antibody and Alexa Fluor 488 conjugated
(dilution 1 : 300; Abcam) in 0.2% BSA/PBS for 1 h on ice.
After two washes in PBS, cells were ﬁxed in 3% PFA and
2% sucrose for 10min. After three washes in PBS, ﬁlters were
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excised and placed side up on a glass slide and overlaid with a
drop of Mowiol (Calbiochem, San Diego, CA, USA) followed
by a coverslip. Cells were analysed by using a Nikon Eclipse
Ti-E C2 confocal microscope. Specimens were viewed
through a 60x oil immersion objective, with a 2.5 zooming
in some analyses. Digital images were processed by using
the program NIS Element (Nikon). Immunoﬂuorescence
and confocal analysis on CFTR were performed as estab-
lished by us in a previous work on CFBE cells [31].
2.7. Fluorescence Measurements of Apical CFTR-Dependent
Chloride Eﬄux. Chloride eﬄux was measured by using the
Cl−-sensitive dye, N-(Ethoxy-carbonylmethyl)-6-methoxy-
quinolinium bromide (MQAE) as we previously reported
[20]. Brieﬂy, after 6 days of coculture on permeable ﬁlter
inserts, cells were loaded overnight in culture medium
containing 5mM MQAE at 37°C in a CO2 incubator and
then inserted into a perfusion chamber that allowed indepen-
dent perfusion of apical and basolateral cell surfaces. Fluores-
cence was recorded with a Cary Eclipse spectroﬂuorometer
(Varian). To measure chloride eﬄux rate across the apical
membrane, the apical perfusion medium was changed with
a medium in which chloride was substituted with isoosmotic
nitrate. All experiments were performed at 37°C in HEPES-
buﬀered bicarbonate-free media (Cl−medium: 135mMNaCl,
3mM KCl, 1.8mM CaCl2, 0.8mM MgSO4, 20mM HEPES,
1mM KH2PO4, 11mM glucose, and Cl
− free medium:
135mM NaNO3, 3mM KNO3, 0.8mM MgSO4, 1mM
KH2PO4, 20mM HEPES, 5mM Ca(NO3)2, and 11mM
glucose). CFTR-dependent chloride secretion was calculated
as the diﬀerence in the rate of change of forskolin-plus
3-isobutyl-1-methylxanthine- (IBMX-) stimulated ﬂuores-
cence in the absence or presence of apical treatment with
the speciﬁc CFTR inhibitor, CFTRinh-172 [20]. This tech-
nique has been already used by us in the study of the rela-
tionship between CFTR activity as a chloride channel and
cytoskeletal organization in airway epithelial cells [31].
2.8. Western Blotting Analysis. After 16HBE cells, CFBE cells
and hAMSC :CFBE cocultures in various conditions (i.e.,
untransfected and transfected) were cultured for 6 days on
Transwells, monolayers were washed with PBS, homoge-
nized in lysis buﬀer (110mM NaCl, 50mM Tris, Triton X-
100 0.5%, and Igepal CA-630 0.5%, pH8.0, with added
protease inhibitor mixture), sonicated for 10 sec, and centri-
fuged for 10min (16,000×g), and then the pellet was dis-
carded. Supernatant protein concentration was measured,
and an aliquot of 30μg of protein was diluted in Laemmli
buﬀer, heated at 100°C for 5min and separated by 3–8%
Tris-acetate gel (Bio-Rad). The gel was transferred to poly-
vinylidene diﬂuoride membranes (GE Healthcare Italia,
Milan, Italy) and processed for Western blotting by using
monoclonal CFTR antibody (R&D Systems, MAB25031;
dilution 1 : 500), monoclonal Cx43 antibody (CX-1B1; dilu-
tion 1 : 500; Abcam), or monoclonal β-tubulin (dilution
1 : 1000; Sigma-Aldrich). The secondary antibody was anti-
mouse IgG for all primary antibodies (Sigma-Aldrich).
Immunocomplexes were detected with LumiGLO reagent
(Cell Signaling, EuroClone, Milan, Italy), and densitometric
quantiﬁcation and image processing were carried out
by using Adobe Photoshop and the Image software pack-
age (version 1.61, National Institutes of Health, Bethesda,
MD, USA).
2.9. Transepithelial Resistance. TER was measured at day 6,
using chopstick electrodes and a volt-ohm meter (Millicell®
ERS, Millipore).
2.10. Paracellular Permeability. CFBE and CFBE : hAMSC
cocultures, grown for 6 days, were evaluated for paracellular
permeability by adding a FITC-conjugated dextran (10 kDa
[10 s]; Sigma-Aldrich) to the apical side of monolayers. After
20, 40, and 60min, the apparent permeability (pAPP) was
calculated by measuring the ﬂuorescence in the basal
medium, as previously described [8].
2.11. Apoptosis and Necrosis. CFBE cell monolayers and
cocultures at day 6 were evaluated for apoptosis/necrosis
rate by using the FlowCellect™ Annexin Red Kit (Merck
Millipore), according to the manufacturer’s instructions.
Brieﬂy, cells were stained with annexin V conjugated with
a sensitive dye CF647 (excitation laser: 642 nm, emission
max: 670nm) for 15min at 37°C, washed in assay buﬀer,
then stained with 7-AAD (excitation laser: 488 nm, emission
max: 642nm) for 5min and analysed by Amnis FlowSight
IS100 (Merck Millipore). Brightﬁeld aspect ratio versus
brightﬁeld area plots were generated to identify single
cells events, then 20,000 single-cell events for sample were
acquired. Dot plots were obtained by plotting the ﬂuores-
cence of annexin V (channel 11) versus ﬂuorescence of 7-
AAD (channel 5), resulting in four diﬀerent populations:
(1) healthy cells, annexin V(−), and 7-AAD(−); (2) necrotic
cells, annexin V(+), and 7-AAD(+); (3) early apoptotic cells,
annexin V(+), and 7-AAD(−); and (4) late apoptotic cells,
annexin V(−), and 7-AAD(+). This technique has been used
already by us in the study of the hyperthermia eﬀects on
dendritic cells [32] and applied to hAMSC :CFBE cocultures.
2.12. Statistical Analysis. Statistical signiﬁcance of diﬀer-
ences was evaluated by a two-tailed unpaired Student’s
t-test or ANOVA with Tukey’s multiple comparison test.
Data were analysed by using Prism 5 (GraphPad Software
Inc., La Jolla, CA, USA). p values of less than 0.05 were
considered signiﬁcant.
3. Results
3.1. Basal Cx43 mRNA and Protein Expression. In order to
investigate whether Cx43 could be a suitable target to be
downregulated by siRNA, we studied its mRNA levels in
CFBE and hASMCs, when grown on Transwells for 6 days.
For comparison purposes, also 16HBE cells, expressing
wild-type CFTR, were included in the analysis. As shown in
Figure 1(a), CFBE displayed higher levels of Cx43 mRNA
than 16HBE cells (p < 0 05 by unpaired Student’s t-test).
Although Cx43 mRNA levels have the tendency to be higher
in hAMSCs than in both epithelial cell lines, these diﬀerences
were not statistically signiﬁcant.
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When we analysed the expression and localisation of the
Cx43 protein by epiﬂuorescence and confocal microscopy in
the three cell types grown on Transwells for 6 days, the XY
images showed a similar signal in CFBE and 16HBE cells,
localised at the cell borders (Figure 1(b)). hAMSCs were
characterized by Cx43 localisation both at the cell membrane
and within the cytoplasm (Figure 1(b)), a pattern previously
found by Valiunas et al. [33] in MSCs obtained from human
bone marrow that is considered the gold standard in the ﬁeld
of MSCs.
3.2. Downregulation of Cx43 by siRNA. The eﬀect of siRNA
on the target mRNA is exerted in the cytosol through the
RNA-induced silencing complex (RISC) [34]. Thus, we
studied the uptake and internalisation of siRNA by a cyto-
ﬂuorimetric assay, which allows to distinguish between the
extracellular and intracellular siRNA molecules [35]. Since
the target of downregulation studies is the coculture of
hAMSCs and CFBE cells, cocultures at 1 : 5 hAMSC :CFBE
ratio was used in this assay. After 24 h of incubation with
ﬂuorochrome-conjugated siRNA, cells were treated or not
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Figure 1: Basal expression of Cx43mRNA and protein. (a) mRNA levels: CFBE, 16HBE, and hAMSCs were grown on Transwells for 6 days at
conﬂuence and then evaluated by real-time PCR. Values are relative to those of CFBE cells that were set at 1 and are shown as fold change.
Results are shown as mean± SD of three experiments, each carried out in triplicate. ∗p < 0 05. (b) Cx43 protein expression and localisation.
CFBE, 16HBE, and hAMSCs were grown on Transwells for 6 days at conﬂuence and then stained with an Alexa Fluor 488-conjugated
antibody directed against Cx43 (upper panels). As a control for background levels, cells were not treated with the primary antibody (lower
panels). Original magniﬁcation: 60x. Scale bar: 20 μm.
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with trypan blue before analysis. Trypan blue quenches
extracellular ﬂuorescence allowing to determine intracellular
signal only [35]; therefore, whole cell-associated ﬂuorescence
is detected in cells not treated with trypan blue, while
internalised ﬂuorescence is revealed in the treated ones. As
reported in the Supplementary Figure 1, trypan blue-treated
cells show almost 100% of positivity and this percentage is
not diﬀerent from that of cells evaluated in the absence of
trypan blue pretreatment, thereby indicating that internalisa-
tion has occurred in all cells.
siRNA internalisation was investigated in terms of
eﬃcacy as downregulation of Cx43 mRNA and protein,
as well as the inhibition of functional GJs. As shown
in Figure 2(a), only cocultures treated with the Cx43
siRNA show a signiﬁcant decrease in Cx43 mRNA in respect
to both untreated cocultures and coculture transfected
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(b)
Figure 2: Downregulation of Cx43 mRNA and protein induced by a speciﬁc siRNA in cocultures. (a) Cx43 mRNA levels. 1 : 5 hAMSC : CFBE
cocultures were transfected with either Cx43 siRNA or scrambled siRNA for 6 days. In parallel, other cocultures were not transfected and
Cx43 mRNA levels obtained from these cocultures were set at 1. Data are shown as mean± SD of three experiments, each carried out in
duplicate. ∗∗∗p < 0 0001 versus untransfected cocultures. (b) Cx43 protein levels and localisation. With the same experimental setting
described in (a), cocultures were evaluated for Cx43 protein by confocal microscopy. The upper panels refer to cocultures incubated with
the Alexa Fluor 488-conjugated antibody directed against Cx43, while the lower panels to cocultures in the absence of the primary
antibody. Original magniﬁcation: 60x. Scale bar: 20μm.
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with a scrambled siRNA, demonstrating the speciﬁc
siRNA eﬀect.
Confocal microscopy revealed that Cx43 is expressed
both at the level of the plasma membrane and cytoplasm
(Figure 2(b)). The treatment with the Cx43siRNA strongly
downregulated the protein at both cellular localisations,
while scrambled siRNA transfection exerted a small decrease
on Cx43 at the plasma membrane level (Figure 2(b)).
In order to study the formation of functional gap
junctions, we used the microinjection of Lucifer yellow
(LY), a ﬂuorescent dye which diﬀuses among cells through
GJs [30]. Texas Red-conjugated dextran was also used to
highlight the injected cells, since it does not pass through
GJs. Cocultures grown on slides displayed a broad diﬀusion
of LY from the injection point, while the treatment with the
active siRNA led to a drastic reduction in cell-to-cell diﬀu-
sion (Figure 3(a)). Cocultures treated with the scrambled
siRNA resembled those untreated. As a positive control of
inhibition of GJCs, HgCl2 (at a subcytotoxic concentration
as low as 10nM) was shown to cause a signiﬁcant reduction
in cell-to-cell coupling after a 24h of incubation. Under
these experimental conditions, autoﬂuorescence levels were
negligible in both green and red channels (Supplementary
Figure 2). siRNA eﬃciency was also tested in cocultures
CTRL siRNA Cx43
Scrambled siRNA Mercury chloride
10 휇m
10 휇m 10 휇m
10 휇m
(a)
CTRL siRNA Cx43 Scrambled siRNA
30 휇m
30 휇m
30 휇m
30 휇m
30 휇m
30 휇m
(b)
Figure 3: Eﬀect of the siRNA Cx43 on Lucifer yellow (LY) diﬀusion in cocultures. (a) Mixed hAMSC-CFBE cells were transfected with siRNA
against Cx43 or the scrambled siRNA or left untreated, cultured on glass slides, and evaluated for LY diﬀusion after 6 days by confocal
microscopy (XY images). As a positive control of GJIC inhibition, 10 nM mercury (II) chloride was added to cocultures on the ﬁfth day.
Original magniﬁcation: 60x and 2.5x zooming. The inset panels show the injected cell indicated by the white arrow. The same cell with the
dextran in red is shown in the side panels. Scale bar: 10μm. (b) Mixed hAMSC-CFBE cells were transfected with siRNA against Cx43 or
the scrambled siRNA or left untreated, cultured on Transwells, and evaluated for LY diﬀusion after 6 days by confocal microscopy (XY
images). Original magniﬁcation: 60x. Scale bar: 30μm.
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seeded onto Transwells, ﬁnding that LY diﬀusion was
almost abolished by the Cx43 siRNA and not by control
siRNA (Figure 3(b)). Altogether, these data show the
important role of Cx43 in the GJ formation and function
in cocultures.
3.3. Reduction in CFTR Protein Expression and Function by
siRNA Downregulation. Having demonstrated that a siRNA
against Cx43 is able to block cell-to-cell communication via
gap junctions, we next evaluated the eﬀect of this siRNA on
CFTR expression and function. In order to demonstrate that
the GJ-mediated intercellular communication is involved in
the rescue of expression, localisation, and function of CFTR
protein, hAMSC-CFBE mixed cells (at the 1 : 5 ratio) were
transfected with either Cx43 siRNA or scrambled siRNA or
left untreated and then cocultured on Transwells. As shown
in Figure 4(a), confocal analysis of the CFTR protein dis-
tribution showed that in untransfected cocultures as well
as in cocultures transfected with the scrambled siRNA,
CFTR was localised at the apical membrane, whereas Cx43
silencing resulted in the disappearance of CFTR from this
cellular region.
CFTR is a glycoprotein that exits from the endoplasmic
reticulum (ER) as 160 kDa immature form (band B) and then
is further glycosylated to a 180 kDa mature form (band C),
which is ﬁnally transported to the plasma membrane. We
conﬁrmed confocal microscopy results by Western blotting
analysis performed in 16HBE (endogenously expressing wt
CFTR and therefore used as a reference to the location of
band C and band B of wt CFTR), CFBE, hAMSCs, and cocul-
tures transfected with either siRNA for Cx43 or scrambled
siRNA grown on Transwells. Figure 4(b) shows a typical
Western blot; in 16HBE cells, the mature band C of CFTR
was strongly expressed; on the contrary, in the CFBE cells,
F508del CFTR was almost completely absent as well as in
hAMSCs. As we previously showed [18], 1 : 5 hAMSC :CFBE
cocultures displayed an increase in the mature band C,
indicating the rescue of CFTR maturation defect occurring
in CFBE cells. Interestingly, band C almost completely
disappeared when cocultures were transfected with siRNA
for Cx43 but not with a scrambled siRNA, whereas band B
intensity did not change (Figure 4(b)). Densitometric analy-
sis revealed that Cx43 silencing signiﬁcantly reduced CFTR
protein expression (shown as band C/band B ratio) by 33%
in respect to nontransfected (CTRL) or scrambled siRNA-
treated cells (Figure 4(b)).
To determine whether the rescue of CFTR-dependent
chloride secretion in cocultures is aﬀected by Cx43-
dependent permeability, cells were transfected with the
siRNA against Cx43 or left untreated and then analysed for
apical CFTR-dependent chloride eﬄux. The function of the
CFTR protein was evaluated by spectroﬂuorimetric measure-
ments of chloride eﬄux detecting the change in ﬂuorescence
(Δ(F/F0)/min) of the chloride sensitive dye MQAE as previ-
ously reported [7]. As shown in Figure 4(c), the CFTR-
dependent chloride eﬄux was similar in untreated cocultures
and in those transfected with the scrambled siRNA. Impor-
tantly, the active siRNA transfection resulted in a signiﬁcant
reduction of chloride eﬄux in comparison to the other two
conditions, suggesting a central role of GJs in the cross-talk
between hAMSCs and CFBE cells and the rescue of CFTR
protein expression and function.
3.4. Cx43 Downregulation Determines a Decrease in
Transepithelial Resistance. In CFBE cells, CFTR overexpres-
sion has been shown to increase both the CFTR traﬃcking
to the plasma membrane and the transepithelial resistance
(TER) while reducing the permeability to small molecules
[36]. Therefore, we considered the epithelial resistance as a
representative measurement of wt CFTR expression and
transport to the apical membrane. We found that in compar-
ison with the CFBE cells, the CFBE : hASMC cocultures, on
the sixth day, displayed a signiﬁcantly higher TER values
than the CFBE cells (Figure 5(a)). As expected, Cx43 siRNA
transfection of cocultures signiﬁcantly reduced TER, while
the scrambled siRNA transfection was ineﬀective with
respect to control cocultures. To understand whether the
changes in TER could be biologically relevant, we studied
the paracellular permeability to a FITC-conjugated dextran
(10 s; 10,000Da). As shown in Figure 5(b), the pAPP was
signiﬁcantly lower in control CFBE : hAMSC cocultures,
paralleling the increase in TER. Cx43 siRNA transfection
of cocultures leads to a signiﬁcant increase in pAPP as
compared with both controls and cocultures transfected
with the scrambled siRNA.
In order to see whether TER alterations could be due to a
marked modiﬁcation of viability, we analysed apoptosis and
necrosis by a cytoﬂuorimetric assay (Figure 5(c)). Although
there was a signiﬁcant decrease in cell viability in control
cocultures and cocultures transfected with scrambled siRNA
as compared with CFBE single cultures (Supplementary
Table 1), the percentages of viable (7-AAD(−) and annexin
V(−)), necrotic (7-AAD(+) and annexin V(+)), early apo-
ptotic (7-AAD(−) and annexin V(+)), and late apoptotic
(7-AAD(+) and annexin V(−)) cells were not diﬀerent
among control cocultures and cocultures transfected with
either Cx43 or the scrambled siRNA. These results make
unlikely that TER and pAPP alterations are determined by
a change in cell viability.
4. Discussion
MSCs have been shown to produce a wealth of healthy eﬀects
on the respiratory tract in many pathological conditions,
including acute and chronic lung diseases [18, 19, 37]. MSCs
might provide the tissue microenvironment with paracrine
mediators which act on the diﬀerent cellular structural
components of the lung and which can have cytoprotective
eﬀects, as well as anti-inﬂammatory and immunomodulatory
capacities [38]. These therapeutic eﬀects are believed to be
given minimally by their transdiﬀerentiation to epithelial
cells [39]. Nevertheless, it has been shown that human
lung-resident MSCs, when administered to the mouse lung,
can establish GJ communications with lung alveolar and
bronchial epithelial cells and persist for up to 6 months
[40]. Therefore, it is likely that a combination of paracrine
and GJ-mediated factors might contribute to the therapeutic
eﬀects of MSCs at the level of the respiratory mucosa.
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This study underlines the relevance of GJs in the rescue of
CFTR protein expression and function as a chloride channel
in CFBE : hAMSCs cocultures. Notably, the siRNA directed
against Cx43 strongly reduced band C but not band B of
CFTR; these results correlate with the signiﬁcant decrease
in CFTR protein localisation at the level of the plasma
membrane and in CFTR chloride channel activity. By using
the same confocal microscopic and ﬂuorimetric assays, we
have previously shown that CFBE cells display a lack of
CFTR protein apical localisation and function that correlated
with defective accumulation of cAMP in the subcortical
compartment and reduced subcortical levels of PKA activity
[31]. These alterations would be worth to be studied in
cocultures before and after Cx43 siRNA transfection. At the
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Figure 4: Eﬀect of Cx43 siRNA on CFTR protein localisation, expression, and function. (a) Confocal microscopy of cocultures after 6 days
from the transfection with either siRNA against CX43 or scrambled siRNA. Cocultures were stained with an anti-CFTR primary antibody
followed by an Alexa Fluor 488-conjugated secondary antibody (green) and DAPI (blue). XZ images are shown. Original magniﬁcation:
60x. Scale bar: 10 μm. (b) Representative Western blot of a typical experiment analysed using anti-human CFTR C-terminus antibody
(dilution 1 : 500), anti-Cx43 (dilution 1 : 500), anti β-tubulin (dilution 1 : 1000). β-Tubulin was used to normalise protein loading. The
histogram summarises the relative change in the ratio between band C and band B in the various conditions compared to the CFTR ratio
in the 16HBE set as 1. Results represent means± SEM of three experiments. ∗∗∗p < 0 0001. (c) CFTR-dependent chloride eﬄux analysed
under the same experimental conditions. Data are shown as mean± SD of three experiments. ∗∗∗p < 0 0001.
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moment, we are not able to explain why siRNA Cx43 does
not modify CFTR-B expression, whereas it reduces CFTR-C
expression. We can only hypothesise that the absence of
modiﬁcation in core-glycosylated band B could be conse-
quent to the fact that Cx43 silencing induces an alteration
of the ubiquitin proteasome pathway, which has been
demonstrated to regulate CFTR degradation [41], or leads
to its stabilization in the ER. Further studies are required to
clarify these hypotheses.
These ﬁndings may be relevant to understand the
mechanism of rescue of CFTR-dependent chloride eﬄux in
the nose and rectum of CF mice with the administration of
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Figure 5: Eﬀect of Cx43 siRNA on transepithelial resistance and cell viability. (a) Trans-epithelial resistance (TER; ohm cm2) was measured
after 6 days from the transfection with either siRNA against Cx43 or scrambled siRNA. Untreated cocultures (CTRL) and CFBE cells cultured
on Transwells were also analysed. Data were obtained from three experiments, each carried out in quadruplicate. Results are shown as
mean± SEM. ∗∗p < 0 01; ∗∗∗p < 0 0001. (b) Paracellular permeability (pAPP; cm/s) was measured after 6 days in the same experimental
conditions as in (a). Data were obtained from three experiments, each carried out in triplicate. Results are shown as mean± SEM. ∗∗p < 0 01.
(c) Representative dot plot showing viable (7-AAD(−) and annexin V(−)), necrotic (7-AAD(+) and annexin V(+)), early apoptotic
(7-AAD(−) and annexin V(+)), and late apoptotic (7-AAD(+) and annexin V(−)) cells in all conditions as in (a). One representative
experiment is shown.
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hematopoietic stem cells [42] or mesenchymal stem cells [43]
derived from the bone marrow which resulted in modest or
rare appearance of stem cell-derived epithelial cells in the
lung, suggesting that few stem cells homed to the CF lung
may trigger correction of CFTR defects in ion transport
via cell-to-cell communications. The type of intercellular
junctions that can be formed during cocultures is yet to
be elucidated. Islam and colleagues found that Cx43-GJs
mediated both cytoplasmic and mitochondrial transfer
from bone marrow MSCs to alveolar epithelial cells [44].
On the other hand, it has been recently demonstrated that
MSCs, both resident in the lung and bone marrow-derived,
employ non-Cx43-GJs in the transfer of cytoplasmic content
and mitochondria to bronchial epithelial cells in vitro [45].
Thus, it is possible that hAMSCs, once acquired an epithelial
phenotype, may interact with bronchial epithelial cells
through diﬀerent types of GJs.
In the airways, GJs regulate Ca2+ wave propagation [46]
and ciliary beat frequency [47] and coordinated secretion of
airway surface ﬂuid [27] and mucins [48], as well as innate
immune functions of the epithelial layer [48–51]. Our
previously published data [20] strongly suggested that
intercellular communication is involved in the rescue of
CF-associated basic defects by hAMSCs in coculture with
CFBE cells. The mechanistic relationship between GJs and
CFTR is not known at the moment; Chanson and colleagues
[52] have suggested that CFTR may inﬂuence the function of
GJs in a variety of cells, including pancreatic duct and airway
epithelial cells. This study demonstrates that the interaction
of CFTR with other intracellular proteins may provide a
molecular mechanism for the regulation of GJ channels.
Interestingly, our data indicate that the presence of func-
tional GJs may allow the cell-to-cell transport of media-
tors that could rescue the correct localisation of the
CFTR protein and its function as a chloride channel.
One hypothesis is that interference with GJ function
may aﬀect chloride eﬄux, as chloride from adjacent CF
cells fails to diﬀuse through gap junctions into hAMSCs
where CFTR functions and secretes chloride normally.
Alternatively, transfer of miRNAs could be involved. At
the moment, several miRNAs expressed in primary
human epithelial cells which directly repress CFTR expres-
sion by binding to the 3′ UTR of the transcript have been
identiﬁed [53–56]. On the other hand, in polarized Calu-3
epithelia, Ramachandran et al. [55] found that miR-138
increased CFTR mRNA and protein levels as well as
CFTR-mediated Cl− conductance.
In this study, we found that siRNA downregulation of
Cx43 brought to a decrease in TER and a corresponding
increase in paracellular permeability in the absence of overt
cytotoxicity or induction of apoptosis. Notably, we recently
used the same cytoﬂuorimetric assay to show that dendritic
cells undergo necrosis and apoptosis following their exposure
to 39°C [32], suggesting that our transfection conditions do
not cause any harm to cocultures of hAMSC with airway
epithelial cells. These results are in agreement with our previ-
ous results showing that hAMSC :CFBE cocultures displayed
a corrected CFTR protein in association with an increase in
ZO-1 localisation at the intercellular borders [20]. Thereby,
Cx43 siRNA, abrogating CFTR rescue on the plasma mem-
brane, may alter the tightness of the airway epithelium by
an indirect mechanism. This hypothesis ﬁts with the indi-
cations that CFTR expression may inﬂuence the epithe-
lium tightness. LeSimple and colleagues, in fact, found that
overexpression of CFTR in CFBE cells increased TER and
reduced mannitol permeability [36]. In keeping with these
results, Castellani et al. [8] demonstrated that overexpression
of CFTR or its interacting protein NHERF1 in CFBE cell
monolayers induced the reorganisation of TJ proteins at the
level of intercellular junctions and reduced the paracellular
permeability to dextrans. Nevertheless, because the pathway
of shuttling chloride to hAMSCs is disrupted, less chloride
and consequently sodium and other cations may be trans-
ported less. Thus, TER is increased. TER is widely accepted
as a measure of paracellular permeability and reﬂects the
ionic conductance of the paracellular pathway in the epithe-
lial monolayer [57]. However, recently, Molina et al. [28]
have shown that CF airway epithelial cells (CuFi) display a
lower TER, similar expression of TJ proteins (ZO-1 and
ZO-2) on the plasma membrane and a Cx43 mistraﬃcking
to the plasma membrane as compared with wild-type cells
(NuLi), suggesting that a defect in gap junctions might inﬂu-
ence TER. Overall, these results imply a role for CFTR
expression and function in the correct assembly and function
of tight and gap junctions.
Although derived from an in vitro study, these results
may have consequences in the context of in vivo applica-
tion of hAMSCs to the diseased CF lung. Indeed, the
administration of hAMSCs may have a double outcome:
(i) to replenish the stem cell niche in the airways with
multipotent stem cells that could give rise to the diﬀeren-
tiated cell types; and (ii) to contribute to the airway phys-
iology by interacting via GJ with resident airway epithelial
cells. What is unknown at the moment is if hAMSCs can
be administered as such or should be instructed by signals
derived from epithelial cells in vitro before their instilla-
tion to the lung conduits. Another point which deserves
further studies is which should be the best way to administer
MSCs to the CF lung [58]. Local (intratracheal) would be
preferred to avoid systemic side eﬀects, allocation of MSCs
in the proximity of the injury site(s) and possibly of endoge-
nous stem cell niches in the airways. However, the CF epithe-
lium is covered in vivo by a dense mucus; therefore,
mucolytics could be adjuvant in this scenario. A systemic
administration (intravenous) of MSCs is also appealing due
to the pulmonary “ﬁrst pass” eﬀect [59, 60]. Recent clinical
data show that the systemic administration of MSCs to
patients with various lung diseases has proved to be safe
[61], and there are two ongoing phase I clinical trials in CF
with MSC infusion (NCT02866721 and NCT03058068, see
https://clinicaltrials.gov). However, whether inﬂammatory
mediators (cytokines and chemokines) also increase the
potential of MSCs to home, adhere to, and repair damaged
airway epithelium is largely unknown. This is an issue which
should be elucidated in future experiments to better under-
stand the mechanism on how MSCs could be therapeutic
for inﬂamed CF lung disease whether administered locally
or systemically.
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5. Conclusion
This study highlights the importance of GJs in the cross-talk
occurring between mesenchymal stem cells and epithelial cells
with CF leading to the rescue of a functional CFTR protein. It
should be stressed that MSCs are able to secrete a host of para-
crine factors with anti-inﬂammatory, immunomodulating, and
anti-infective eﬀects. As CF lung pathology is characterised by
chronic inﬂammation and infections, future work should
assess whether hAMSCs are useful in this context, besides the
rescue of a mature and functional CFTR protein. Finally,
in vivo studies on the role of direct coupling of hAMSCs and
CF epithelial cells in the rescue of CFTR defects are deserved.
Disclosure
The content of this paper was partially presented as oral
communication at the 39th European Cystic Fibrosis Confer-
ence held in Basel, Switzerland, on 8–11 June 2016. The
abstract has been published on the J Cyst Fib 2016, 15, S10.
Conflicts of Interest
The authors declare that there are no conﬂicts of interest
regarding the publication of this paper.
Authors’ Contributions
Maria Favia and Massimo Conese share the last authorship.
Acknowledgments
This work was supported by the Italian law 548/93. Stefano
Castellani is a researcher funded by Intervento Coﬁnanziato
dal Fondo di Sviluppo e Coesione 2007-2013—APQ Ricerca
Regione Puglia, “Programma regionale a sostegno della
specializzazione intelligente e delle sostenibilità sociale ed
ambientali—Future In Research.”
Supplementary Materials
Supplementary Figure 1: internalisation of siRNA. Cocultures
of hASMCs and CFBE (1 : 5 ratio) were transfected with a
FITC-conjugated siRNA (see Materials and Methods). After
24h, cells were treated or not with trypan blue (TB) prior to
cytoﬂuorimetric analysis. Results are shown as mean± SD
obtained from n = 2 experiments, each carried out in triplicate.
Supplementary Figure 2: immunoﬂuorescence controls.
Cocultures of hASMCs and CFBE (1 : 5 ratio) were stained
with DAPI and observed either at the DAPI channel (a), FITC
channel (b), or TRITC channel (c). DAPI ﬁlter: 358nm excita-
tion, 461nm emission; FITC ﬁlter: 490nm excitation, 525nm
emission; TRITC ﬁlter: 532nm excitation, 570nm emission.
Supplementary Table 1: eﬀect of siRNA transfection on cell
viability. (Supplementary Materials)
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